Cargando…

A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure

Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muramatsu, Tomoaki, Funahashi, Yasuhito, Yamamoto, Akiyuki, Sassa, Naoto, Matsukawa, Yoshihisa, Gotoh, Momokazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nagoya University 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892669/ https://www.ncbi.nlm.nih.gov/pubmed/31849389 http://dx.doi.org/10.18999/nagjms.81.4.707

Ejemplares similares

Therapeutic effect of adipose-derived regenerative cells on bladder function in rats with underactive bladder
por: Mori, Aya, et al.
Publicado: (2020)

THE RENAL TUMOR MORPHOLOGICAL CHARACTERISTICS THAT AFFECT SURGICAL PLANNING FOR LAPAROSCOPIC OR OPEN PARTIAL NEPHRECTOMY
por: FUNAHASHI, YASUHITO, et al.
Publicado: (2015)

Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney
por: Tochigi, Kosuke, et al.
Publicado: (2019)

Response to flutamide, as second-line therapy after bicalutamide, predicts efficacy of abiraterone, not that of enzalutamide
por: Nakai, Yasushi, et al.
Publicado: (2018)

Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade
por: Yokomizo, Yumiko, et al.
Publicado: (2016)

Feasibility of the Lilium α-200 portable ultrasound bladder scanner for accurate bladder volume measurement
por: Majima, Tsuyoshi, et al.
Publicado: (2020)

Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem Cells
por: Yamamoto, Tokunori, et al.
Publicado: (2016)

Influence of human adipose stem cells on prostate cancer cell growth
por: Tokunori Yamamoto,, et al.
Publicado: (2020)

Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study)
por: Iguchi, Taro, et al.
Publicado: (2019)

Design of a single-arm clinical trial of regenerative therapy by periurethral injection of adipose-derived regenerative cells for male stress urinary incontinence in Japan: the ADRESU study protocol
por: Shimizu, Shinobu, et al.
Publicado: (2017)

The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate—a long-term follow-up comparison and quality of life analysis
por: Dijkstra, Siebren, et al.
Publicado: (2016)

Acute liver failure and liver transplantation secondary to flutamide treatment in a prostate cancer patient
por: Rojas, Pablo A., et al.
Publicado: (2020)

Successful recovery from multiple organ failure associated with bicalutamide and leuprorelin acetate for prostate cancer
por: Saito, Seiichi
Publicado: (2019)

Effect of Bicalutamide Combined with Docetaxel on Serum PSA and VEGF Levels in Patients with Advanced Prostate Carcinoma
por: Guo, Zhaoxin, et al.
Publicado: (2022)

Spectrophotometric Estimation of Bicalutamide in Tablets
por: Sancheti, P. P., et al.
Publicado: (2008)

Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer
por: Kandil, Sahar B., et al.
Publicado: (2020)

Evaluation of (11)C-choline PET/CT for primary diagnosis and staging of urothelial carcinoma of the upper urinary tract: a pilot study
por: Sassa, Naoto, et al.
Publicado: (2014)

Long Term Progression-Free Survival in a Patient with Locally Advanced Prostate Cancer under Low Dose Intermittent Androgen Deprivation Therapy with Bicalutamide Only
por: Latz, Stefan, et al.
Publicado: (2015)

Efficacy of Bicalutamide 150-mg Monotherapy Compared With Combined Androgen Blockade in Patients With Locally Advanced Prostate Cancer
por: Kang, Yu Jin, et al.
Publicado: (2014)

Bicalutamide Activated Oncolytic Adenovirus for the Adjuvant Therapy of High Risk Prostate Cancer
por: Johnson, Tamara Jane, et al.
Publicado: (2013)

Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer
por: Li, Yuezheng, et al.
Publicado: (2023)

Compression-Induced Phase Transitions of Bicalutamide
por: Szafraniec-Szczęsny, Joanna, et al.
Publicado: (2020)

Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models
por: SQUILLACE, RACHEL M., et al.
Publicado: (2012)

The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer
por: Tian, Lei, et al.
Publicado: (2022)

Effects of Herpes Simplex Virus Vectors Encoding Poreless TRPV1 or Protein Phosphatase 1α in a Rat Cystitis Model induced by Hydrogen Peroxide
por: Takai, Shun, et al.
Publicado: (2017)

The Effect of Flutamide on Ovulation Induction in PCOS Patients
por: Madani, Tahereh, et al.
Publicado: (2012)

Effects of testosterone and flutamide on reproduction in Brachionus calyciflorus
por: Tian, Jian, et al.
Publicado: (2017)

Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients
por: Corrie, P, et al.
Publicado: (2002)

Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate Cancer()
por: Hongo, Hiroshi, et al.
Publicado: (2014)

Bicalutamide-induced hepatotoxicity: A rare adverse effect
por: Hussain, Salwa, et al.
Publicado: (2014)

Mesotherapy with Bicalutamide: A New Treatment for Androgenetic Alopecia
por: Gomez-Zubiaur, Alba, et al.
Publicado: (2023)

Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications
por: Mora-Rodríguez, José María, et al.
Publicado: (2023)

The effect of Ganoderma lucidum polysaccharide extract on sensitizing prostate cancer cells to flutamide and docetaxel: an in vitro study
por: Rahimnia, Ramin, et al.
Publicado: (2023)

Prophylactic Breast Bud Radiotherapy for Patients Taking Bicalutamide: Should This Still Be Practised for Patients with Prostate Cancer?
por: Lewis, R., et al.
Publicado: (2012)

Editorial Comment to Primary basal cell carcinoma of the prostate with concurrent adenocarcinoma
por: Funahashi, Yasuhito
Publicado: (2020)

Design and Evaluation of Self-Nanoemulsifying Drug Delivery System of Flutamide
por: Jeevana, Jyothi B, et al.
Publicado: (2011)

Flutamide-induced alterations in transcriptional profiling of neonatal porcine ovaries
por: Knapczyk-Stwora, Katarzyna, et al.
Publicado: (2019)

Data-Driven Modeling of the Bicalutamide Dissolution from Powder Systems
por: Mendyk, Aleksander, et al.
Publicado: (2020)

Physicochemical Profile of Antiandrogen Drug Bicalutamide: Solubility, Distribution, Permeability
por: Volkova, Tatyana V., et al.
Publicado: (2022)

Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study
por: Uemura, Hiroji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f7fc2dhhop4jtbcfrpsdqolmkl